Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for ALKS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Max Drawdown (5Y) Data

View and export this data back to 1994. Start Trial.
Date Value
July 31, 2026 68.08%
June 30, 2026 68.08%
May 31, 2026 68.08%
April 30, 2026 68.08%
March 31, 2026 72.08%
February 28, 2026 72.93%
January 31, 2026 72.93%
December 31, 2025 72.93%
November 30, 2025 77.21%
October 31, 2025 79.66%
September 30, 2025 80.80%
August 31, 2025 80.80%
July 31, 2025 80.80%
June 30, 2025 80.80%
May 31, 2025 80.80%
April 30, 2025 82.86%
March 31, 2025 83.39%
February 28, 2025 83.70%
January 31, 2025 83.70%
December 31, 2024 83.70%
November 30, 2024 83.70%
October 31, 2024 83.70%
September 30, 2024 83.70%
August 31, 2024 83.70%
July 31, 2024 83.70%
Date Value
June 30, 2024 83.70%
May 31, 2024 83.70%
April 30, 2024 83.70%
March 31, 2024 83.70%
February 29, 2024 83.70%
January 31, 2024 83.70%
December 31, 2023 83.70%
November 30, 2023 83.70%
October 31, 2023 83.70%
September 30, 2023 83.70%
August 31, 2023 83.70%
July 31, 2023 83.70%
June 30, 2023 83.70%
May 31, 2023 83.70%
April 30, 2023 83.70%
March 31, 2023 83.70%
February 28, 2023 83.70%
January 31, 2023 83.70%
December 31, 2022 83.70%
November 30, 2022 83.70%
October 31, 2022 83.70%
September 30, 2022 83.70%
August 31, 2022 83.70%
July 31, 2022 83.70%
June 30, 2022 83.70%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Amarin Corp. Plc 98.07%
Jazz Pharmaceuticals Plc 47.55%
Prothena Corp. Plc 94.19%
ACADIA Pharmaceuticals, Inc. 77.18%
Biogen, Inc. 72.66%